Maldives vs Pakistan: Access to anti-retroviral drugs, female
Maldives
21.0%
in 2024
Pakistan
24.0%
in 2024
Maldives rank
138th
Pakistan rank
136th
Access to anti-retroviral drugs, female over time
- Maldives
- Pakistan
How they compare
Pakistan currently reports 24.0% against 21.0% in Maldives, a difference of 3.0%.
That makes Pakistan's figure about 1.1 times Maldives's.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Pakistan ahead.
Maldives ranks 138th and Pakistan ranks 136th of 141 countries.
Maldives has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Maldives | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.7% | 2.4% | 6.3% | Maldives |
| 2010s | 8.4% | 6.9% | 1.5% | Maldives |
| 2020s | 20.2% | 17.8% | 2.4% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Maldives or Pakistan?
- Pakistan, at 24.0% against 21.0% in Maldives as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Maldives and Pakistan?
- 3.0%, with Pakistan ahead.
- How many years of comparable data are there for Maldives and Pakistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Maldives and Pakistan rank globally for access to anti-retroviral drugs, female?
- Maldives ranks 138th and Pakistan ranks 136th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.